Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria

References

• WHO. World malaria report 2008. WHO, Geneva, Switzerland (2008).
   Google Scholar
• Snow RW, Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv. Parasitol.52, 235–264 (2002).
   PubMed Web of Science ®Google Scholar
• Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature434(7030), 214–217 (2005).
   PubMed Web of Science ®Google Scholar
• Idro R, Aloyo J, Mayende L, Bitarakwate E, John CC, Kivumbi GW. Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Trop. Med. Int. Health11(1), 115–124 (2006).
   PubMedGoogle Scholar
• Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am. J. Trop. Med. Hyg.64(1–2 Suppl.), 57–67 (2001).
   PubMed Web of Science ®Google Scholar
• Reyburn H, Mbatia R, Drakeley C et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA293(12), 1461–1470 (2005).
   PubMed Web of Science ®Google Scholar
• Oduro AR, Koram KA, Rogers W et al. Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malar. J.6, 96 (2007).
   PubMed Web of Science ®Google Scholar
• Kahigwa E, Schellenberg D, Sanz S et al. Risk factors for presentation to hospital with severe anaemia in Tanzanian children: a case–control study. Trop. Med. Int. Health7(10), 823–830 (2002).
   PubMedGoogle Scholar
• John CC, Bangirana P, Byarugaba J et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics122(1), e92–e99 (2008).
   PubMed Web of Science ®Google Scholar
• Imbert P, Sartelet I, Rogier C, Ka S, Baujat G, Candito D. Severe malaria among children in a low seasonal transmission area, Dakar, Senegal: influence of age on clinical presentation. Trans. R. Soc. Trop. Med. Hyg.91(1), 22–24 (1997).
   PubMed Web of Science ®Google Scholar
• Boivin MJ, Bangirana P, Byarugaba J et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics119(2), e360–e366 (2007).
   PubMed Web of Science ®Google Scholar
• Boivin MJ. Effects of early cerebral malaria on cognitive ability in Senegalese children. J. Dev. Behav. Pediatr.23(5), 353–364 (2002).
   PubMed Web of Science ®Google Scholar
• van Hensbroek MB, Palmer A, Jaffar S, Schneider G, Kwiatkowski D. Residual neurologic sequelae after childhood cerebral malaria. J. Pediatr.131(1 Pt 1), 125–129 (1997).
   PubMed Web of Science ®Google Scholar
• Roze E, Thiebaut MM, Mazevet D et al. Neurologic sequelae after severe falciparum malaria in adult travelers. Eur. Neurol.46(4), 192–197 (2001).
   PubMedGoogle Scholar
• Taylor TE, Fu WJ, Carr RA et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med.10(2), 143–145 (2004).
   PubMed Web of Science ®Google Scholar
• Grau GE, Taylor TE, Molyneux ME et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med.320(24), 1586–1591 (1989).
   PubMed Web of Science ®Google Scholar
• Clark IA, Alleva LM. Is human malarial coma caused, or merely deepened, by sequestration? Trends Parasitol.25(7), 314–318 (2009).
   PubMed Web of Science ®Google Scholar
• Clark IA, Budd AC, Alleva LM. Sickness behaviour pushed too far – the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma. Malar. J.7, 208 (2008).
   PubMedGoogle Scholar
• John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. Low levels of RANTES are associated with mortality in children with cerebral malaria. J. Infect. Dis.194(6), 837–845 (2006).
   PubMed Web of Science ®Google Scholar
• John CC, Park GS, Sam-Agudu N, Opoka RO, Boivin MJ. Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine41(3), 204–208 (2008).
   PubMed Web of Science ®Google Scholar
• Jain V, Armah HB, Tongren JE et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar. J.7, 83 (2008).
   PubMed Web of Science ®Google Scholar
• Anstey NM, Weinberg JB, Hassanali MY et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med.184(2), 557–567 (1996).
   PubMed Web of Science ®Google Scholar
• Medana IM, Hunt NH, Chan-Ling T. Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia19(2), 91–103 (1997).
   PubMed Web of Science ®Google Scholar
• Jennings VM, Lal AA, Hunter RL. Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect. Immun.66(12), 5972–5979 (1998).
   PubMedGoogle Scholar
• Casals-Pascual C, Idro R, Gicheru N et al. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc. Natl Acad. Sci. USA105(7), 2634–2639 (2008).
   PubMed Web of Science ®Google Scholar
• John CC, Panoskaltsis-Mortari A, Opoka RO et al. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am. J. Trop. Med. Hyg.78(2), 198–205 (2008).
   PubMed Web of Science ®Google Scholar
• Dondorp A, Nosten F, Stepniewska K, Day N, White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet366(9487), 717–725 (2005).
   PubMed Web of Science ®Google Scholar
• Praygod G, de Frey A, Eisenhut M. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review. Malar. J.7, 210 (2008).
   PubMedGoogle Scholar
• White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. The murine cerebral malaria phenomenon. Trends Parasitol.26(1), 11–15 (2010).
   PubMed Web of Science ®Google Scholar
• Maitland K, Pamba A, English M et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin. Infect. Dis.40(4), 538–545 (2005).
   PubMed Web of Science ®Google Scholar
• Warrell DA, Looareesuwan S, Warrell MJ et al. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N. Engl. J. Med.306(6), 313–319 (1982).
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Rustama D, Punjabi NH et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J. Infect. Dis.158(2), 325–331 (1988).
   PubMed Web of Science ®Google Scholar
• Taylor TE, Molyneux ME, Wirima JJ, Borgstein A, Goldring JD, Hommel M. Intravenous immunoglobulin in the treatment of paediatric cerebral malaria. Clin. Exp. Immunol.90(3), 357–362 (1992).
   PubMed Web of Science ®Google Scholar
• Havlik I, Looareesuwan S, Vannaphan S et al. Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg.99(5), 333–340 (2005).
   PubMed Web of Science ®Google Scholar
• van Hensbroek MB, Palmer A, Onyiorah E et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J. Infect. Dis.174(5), 1091–1097 (1996).
   PubMed Web of Science ®Google Scholar
• Das BK, Mishra S, Padhi PK et al. Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults. Trop. Med. Int. Health8(8), 680–684 (2003).
   PubMed Web of Science ®Google Scholar
• Di Perri G, Di Perri IG, Monteiro GB et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J. Infect. Dis.171(5), 1317–1322 (1995).
   PubMed Web of Science ®Google Scholar
• Hemmer CJ, Hort G, Chiwakata CB et al. Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor a levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am. J. Trop. Med. Hyg.56(4), 397–403 (1997).
   PubMed Web of Science ®Google Scholar
• Looareesuwan S, Wilairatana P, Vannaphan S et al. Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. Am. J. Trop. Med. Hyg.58(3), 348–353 (1998).
   PubMed Web of Science ®Google Scholar
• Gordeuk VR, Loyevsky M. Antimalarial effect of iron chelators. Adv. Exp. Med. Biol.509, 251–272 (2002).
   PubMedGoogle Scholar
• Gordeuk V, Thuma P, Brittenham G et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med.327(21), 1473–1477 (1992).
   PubMed Web of Science ®Google Scholar
• Mohanty D, Ghosh K, Pathare AV, Karnad D. Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. Indian J. Med. Res.115, 17–21 (2002).
   PubMed Web of Science ®Google Scholar
• Thuma PE, Mabeza GF, Biemba G et al. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans. R. Soc. Trop. Med. Hyg.92(2), 214–218 (1998).
   PubMed Web of Science ®Google Scholar
• Griffiths MJ, Ndungu F, Baird KL, Muller DP, Marsh K, Newton CR. Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. Br. J. Haematol.113(2), 486–491 (2001).
   PubMed Web of Science ®Google Scholar
• Watt G, Jongsakul K, Ruangvirayuth R. A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. QJM95(5), 285–290 (2002).
   PubMed Web of Science ®Google Scholar
• Charunwatthana P, Abul Faiz M, Ruangveerayut R et al.N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit. Care Med.37(2), 516–522 (2009).
   PubMedGoogle Scholar
• Combes V, Taylor TE, Juhan-Vague I et al. Circulating endothelial microparticles in malawian children with severe falciparum malaria complicated with coma. JAMA291(21), 2542–2544 (2004).
   PubMed Web of Science ®Google Scholar
• Rogerson SJ, Reeder JC, al-Yaman F, Brown GV. Sulfated glycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes. Am. J. Trop. Med. Hyg.51(2), 198–203 (1994).
   PubMed Web of Science ®Google Scholar
• Hemmer CJ, Kern P, Holst FG, Nawroth PP, Dietrich M. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am. J. Trop. Med. Hyg.45(5), 608–612 (1991).
   PubMed Web of Science ®Google Scholar
• Riddle MS, Jackson JL, Sanders JW, Blazes DL. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin. Infect. Dis.34(9), 1192–1198 (2002).
   PubMed Web of Science ®Google Scholar
• White NJ. The treatment of malaria. N. Engl. J. Med.335, 800–806 (1996).
   PubMed Web of Science ®Google Scholar
• Maitland K, Nadel S, Pollard AJ, Williams TN, Newton CR, Levin M. Management of severe malaria in children: proposed guidelines for the United Kingdom. Br. Med. J.331(7512), 337–343 (2005).
   PubMedGoogle Scholar
• Akech S, Gwer S, Idro R et al. Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin. Trials1(5), e21 (2006).
   PubMedGoogle Scholar
• Woodrow CJ, Planche T. Phase III trial of albumin in malaria still lacks scientific justification. PLoS Clin. Trials2(2), e1 (2007).
   Google Scholar
• Krishna S, Supanaranond W, Pukrittayakamee S, Kuile FT, Ruprah M, White NJ. The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria. Br. J. Clin. Pharmacol.41(1), 29–34 (1996).
   PubMed Web of Science ®Google Scholar
• Newton CR, Crawley J, Sowumni A et al. Intracranial hypertension in Africans with cerebral malaria. Arch. Dis. Child.76(3), 219–226 (1997).
   PubMed Web of Science ®Google Scholar
• Namutangula B, Ndeezi G, Byarugaba JS, Tumwine JK. Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial. Malar. J.6, 138 (2007).
   PubMedGoogle Scholar
• Crawley J, Smith S, Kirkham F, Muthinji P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. QJM89(8), 591–597 (1996).
   PubMedGoogle Scholar
• White NJ, Looareesuwan S, Phillips RE, Chanthavanich P, Warrell DA. Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet2(8602), 64–66 (1988).
   PubMedGoogle Scholar
• Crawley J, Waruiru C, Mithwani S et al. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet355(9205), 701–706 (2000).
   PubMed Web of Science ®Google Scholar
• Idro R, Carter JA, Fegan G, Neville BG, Newton CR. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch. Dis. Child.91(2), 142–148 (2006).
   PubMed Web of Science ®Google Scholar
• Chen Q, Pettersson F, Vogt AM et al. Immunization with PfEMP1-DBL1a generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine22(21–22), 2701–2712 (2004).
   PubMed Web of Science ®Google Scholar
• Barfod A, Persson T, Lindh J. In vitro selection of RNA aptamers against a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1. Parasitol. Res.105(6), 1557–1566 (2009).
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Silamut K, Charunwatthana P et al. Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria. J. Infect. Dis.196(3), 460–466 (2007).
   PubMed Web of Science ®Google Scholar
• McCormick CJ, Newbold CI, Berendt AR. Sulfated glycoconjugates enhance CD36-dependent adhesion of Plasmodium falciparum-infected erythrocytes to human microvascular endothelial cells. Blood96(1), 327–333 (2000).
   PubMedGoogle Scholar
• Vogt AM, Barragan A, Chen Q, Kironde F, Spillmann D, Wahlgren M. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1a domain of PfEMP1. Blood101(6), 2405–2411 (2003).
   PubMed Web of Science ®Google Scholar
• Vogt AM, Pettersson F, Moll K et al. Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathog.2(9), e100 (2006).
   Google Scholar
• Serghides L, Patel SN, Ayi K et al. Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria. J. Infect. Dis.199(10), 1536–1545 (2009).
   PubMed Web of Science ®Google Scholar
• Boggild AK, Krudsood S, Patel SN et al. Use of peroxisome proliferator-activated receptor γ agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis.49(6), 841–849 (2009).
   PubMed Web of Science ®Google Scholar
• Marsh K, English M, Crawley J, Peshu N. The pathogenesis of severe malaria in African children. Ann. Trop. Med. Parasitol.90(4), 395–402 (1996).
   PubMed Web of Science ®Google Scholar
• Penet MF, Abou-Hamdan M, Coltel N et al. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc. Natl Acad. Sci. USA105(4), 1321–1326 (2008).
   PubMed Web of Science ®Google Scholar
• Vecsei L, Widerlov E. Preclinical and clinical studies with cysteamine and pantethine related to the central nervous system. Prog. Neuropsychopharmacol. Biol. Psychiatry14(6), 835–862 (1990).
   PubMedGoogle Scholar
• Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL. Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr. Opin Infect. Dis.21(5), 468–475 (2008).
   PubMed Web of Science ®Google Scholar
• Yeo TW, Lampah DA, Gitawati R et al. Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J. Infect. Dis.198(4), 602–608 (2008).
   PubMed Web of Science ®Google Scholar
• Marks JD, Schreiber MD. Inhaled nitric oxide and neuroprotection in preterm infants. Clin. Perinatol.35(4), 793–807, viii (2008).
   PubMedGoogle Scholar
• Wiese L, Hempel C, Penkowa M, Kirkby N, Kurtzhals JAL. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar. J.7, 3 (2008).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Silver SM, Djulbegovic B et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA299(8), 914–924 (2008).
   PubMed Web of Science ®Google Scholar
• Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N. Engl. J. Med.355(20), 2085–2098 (2006).
   PubMed Web of Science ®Google Scholar
• Ehrenreich H, Weissenborn K, Prange H et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke40(12), e647–e656 (2009).
   PubMed Web of Science ®Google Scholar
• Picot S, Bienvenu AL, Konate S et al. Safety of epoietin β-quinine drug combination in children with cerebral malaria in Mali. Malar. J.8, 169 (2009).
   PubMed Web of Science ®Google Scholar
• Casals-Pascual C, Idro R, Picot S, Roberts DJ, Newton CR. Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol.25(1), 30–36 (2009).
   PubMedGoogle Scholar
• Okiro EA, Alegana VA, Noor AM, Mutheu JJ, Juma E, Snow RW. Malaria paediatric hospitalization between 1999 and 2008 across Kenya. BMC Med.7, 75 (2009).
   PubMedGoogle Scholar
• O’Meara WP, Bejon P, Mwangi TW et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet372(9649), 1555–1562 (2008).
   PubMed Web of Science ®Google Scholar
• Ceesay SJ, Casals-Pascual C, Erskine J et al. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet372(9649), 1545–1554 (2008).
   PubMed Web of Science ®Google Scholar
• Dondorp AM. Clinical significance of sequestration in adults with severe malaria. Transfus. Clin. Biol.15(1–2), 56–57 (2008).
   PubMed Web of Science ®Google Scholar